Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Globe Life Inc. (NYSE: GL) filings with the U.S. Securities and Exchange Commission, along with AI-generated explanations to help interpret key disclosures. Globe Life is an insurance holding company focused on life and supplemental health insurance, annuities and related investment activities, and its SEC filings offer detailed insight into these operations.
Investors can review current reports on Form 8-K, where Globe Life reports material events such as quarterly earnings releases, changes to executive retirement or compensation plans and significant financing arrangements. For example, recent 8-K filings describe the company’s second and third quarter financial results, an amendment to the Supplemental Executive Retirement Plan and the creation of a pre-capitalized trust securities (P-CAP) program that provides contingent liquidity through senior notes.
Filings also document corporate governance and executive arrangements, including early retirement reduction factors and vesting rules under the SERP in connection with change-of-control protection periods. These disclosures help clarify how Globe Life structures retirement benefits and severance protections for certain executives.
Through this page, users can track debt and capital structure–related disclosures, such as facility agreements, trust arrangements and obligations tied to senior notes and pre-capitalized trust securities. These items illustrate how Globe Life manages liquidity and long-term financing in support of its insurance and investment activities.
The platform supplements raw filings with AI-powered summaries that highlight important sections, explain technical terms and distinguish between GAAP and non-GAAP measures when referenced in attached earnings materials. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured data views make it easier to locate information related to executive plans, financing arrangements and reported results.
Globe Life Inc. received a Rule 144 notice covering a planned sale of 45,000 shares of its common stock through broker APEX Clearing on the NYSE, with an aggregate market value of $6,612,750 and an approximate sale date of 02/06/2026.
The 45,000 shares were acquired on 02/06/2026 via a stock option exercise from Globe Life Inc. Common shares outstanding were 78,637,130. The seller represents that they do not know of any undisclosed material adverse information about Globe Life’s current or prospective operations.
Globe Life Inc. has a planned Rule 144 sale of 30,000 common shares. The shares are to be sold through Apex Clearing on the NYSE, with an approximate sale date of 02/06/2026 and an aggregate market value of $4,408,500.
The 30,000 shares were acquired on 02/06/2026 via a stock option exercise from Globe Life Inc., with payment described as proceeds of the stock option exercise. The filing also notes 78,637,130 shares outstanding for context.
Globe Life Inc. filed a Form 13F reporting institutional holdings: the report lists 2 information-table entries with a total market value of $397,845,466. The report was signed by Christopher T. Moore on 02-06-2026.
Globe Life Inc. filed a current report to note that it issued a press release announcing its fourth quarter 2025 financial results. The press release is attached as Exhibit 99.1 and incorporated by reference.
The company specifies that this earnings information, including Exhibit 99.1, is being furnished under Item 2.02 and is not deemed “filed” under the Exchange Act, which affects how it may be used in certain legal contexts.
The Vanguard Group filed an amended Schedule 13G reporting a passive ownership stake in Globe Life Inc. common stock. It reports beneficial ownership of 10,090,653 shares, representing 12.67% of the outstanding common stock as of the event date.
The Vanguard Group has shared voting power over 704,888 shares and shared dispositive power over 10,090,653 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of Globe Life. Vanguard’s clients have the right to receive dividends and sale proceeds, and no other individual client holds more than 5% of the class. The filing also notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries are expected to report beneficial ownership separately.
Globe Life Inc. director Matthew J. Adams filed an amended insider report after acquiring additional company stock. On January 2, 2026, he acquired 1,373 shares of Globe Life common stock at a reported price of $0 per share, increasing his direct holdings.
Following this transaction, Adams now beneficially owns 2,558.3971 Globe Life shares directly and holds no shares indirectly. The amendment clarifies that this total was corrected to include 2.3971 shares previously acquired through the company’s dividend reinvestment plan, while noting that the original filing was submitted on time.
Globe Life Inc. (GL) director reports stock acquisition
A Globe Life Inc. director, Marilyn A. Alexander, reported acquiring 458 shares of the company’s common stock on 01/02/2026 at a stated price of $0 per share. After this transaction, she beneficially owns 22,606.7364 shares of Globe Life common stock in direct ownership.
The footnote explains that this total includes 102.7315 dividend right restricted stock units that were acquired on restricted stock units since the date of the last report. No derivative securities transactions were reported in this filing.
Globe Life Inc. (GL) director reports stock acquisition
A director of Globe Life Inc., Linda L. Addison, reported acquiring 723 shares of Globe Life common stock on 01/02/2026 in a transaction coded "A" at a price of $0 per share. Following this transaction, she beneficially owns 20,406.1005 shares of Globe Life common stock in direct form. The filing notes that this total includes 140.5747 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of the last report.
Globe Life Inc. director reports acquisition of company stock
A Globe Life Inc. director reported acquiring 1,373 shares of the company’s common stock on 01/02/2026 at a stated price of $0 per share. Following this transaction, the director beneficially owns 10,835.951 shares directly and no shares indirectly. The filing notes that this total includes 52.429 shares acquired through the company’s dividend reinvestment plan since the date of the last report.
Globe Life Inc. director reports stock acquisition
A director of Globe Life Inc. reported acquiring 1,373 shares of the company’s common stock on 01/02/2026 at a reported price of